<DOC>
	<DOCNO>NCT03002844</DOCNO>
	<brief_summary>BIM deletion polymorphism might associate poor clinical response EGFR-TKIs patient NSCLC EGFR mutation . In study , investigator want use EGFR-TKI with/without chemotherapy first line treatment stage IIIB/IV NSCLC patient EGFR mutation BIM deletion polymorphism .</brief_summary>
	<brief_title>EGFR-TKI With/Without Chemotherapy NSCLC Patients With Both EGFR Mutation BIM Deletion Polymorphism</brief_title>
	<detailed_description>BIM deletion polymorphism poor clinical response marker EGFR-TKIs NSCLC patient EGFR mutation . In study , investigator want use EGFR-TKI chemotherapy 1 st treatment stage IIIB/IV NSCLC patient EGFR mutation BIM deletion polymorphism .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>1 . Signed informed consent 2 . Histologically document , unresectable , inoperable , locally advanced , recurrent metastatic Stage IV NonSmall Cell Lung Cancer ( NSCLC ) 3 . Must measurable nonmeasurable disease 4 . Must able comply study followup procedure 1 . Small cell , carcinoid , mixed small cell lung cancer 2 . Malignancies within 3 year except adequately treat carcinoma situ cervix basal squamous cell skin cancer 3 . Symptomatic untreated brain metastasis Prior systemic chemotherapy NSCLC 4 . Unstable systemic disease , include active infection , uncontrolled hypertension , unstable angina , congestive heart failure , myocardial infarction within 6 month prior Day 1 , serious cardiac arrhythmia require medication 5 . History disease , metabolic dysfunction , physical examination finding , clinical laboratory find give reasonable suspicion disease condition contraindicate use investigational drug might affect interpretation result study render patient high risk treatment complication 6 . Gastrointestinal tract disease result inability take oral medication requirement intravenous ( IV ) alimentation , prior surgical procedure affect absorption 7 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>